Moderna’s results came as demand for its Covid-19 vaccine steadied following a prolonged decline. Humana said it had paid out slightly less of its premium revenue on medical expenses in the latest quarter, alongside raising its earnings projection for 2026.
In section Market Quotes
Health-Care Stocks Hold Steady as Investors Favor Cyclicals
Health-care companies were little changed despite strong earnings, as traders shifted back toward cyclical sectors after strong jobs data. Moderna reported a third-quarter profit and lifted its full-year revenue growth forecast, while Humana shares gained on a higher 2026 earnings projection.
Comments (0)
No comments yet. Be the first!